Concepedia

Gabriel I. Uwaifo

GI

41

Publications

9.4K

Citations

26

H-Index

2000

Active since

Affiliations

National Institutes of Health(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

George Washington University

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Harvard University

Gabriel I. Uwaifo is an author at National Institutes of Health specializing in medicine, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

2000–2024

41

Publications

41

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡

Kittichai Promrat, Glen Lutchman, Gabriel I. Uwaifo et al. · Hepatology · 2004 · 723 citations · Full text

The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults

Shamik Parikh, Marni Edelman, Gabriel I. Uwaifo et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 657 citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Rows per page

1–5 of 41